CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | HEDRICK MARC H Chief Executive Officer | Option exercise · Restricted Stock Units | −6,387 | 163,650 | ||
| 2026-07-01 | HEDRICK MARC H Chief Executive Officer | Option exercise · Restricted Stock Units | −8,066 | 155,584 | ||
| 2026-07-01 | HEDRICK MARC H Chief Executive Officer | Option exercise · Restricted Stock Units | −1,986 | 153,598 | ||
| 2026-07-01 | Clowes Howard Director | Option exercise | +922 | 1,981 | ||
| 2026-07-01 | Clowes Howard Director | Option exercise · Restricted Stock Units | −922 | 2,764 | ||
| 2026-05-14 | van Es-Johansson An Director | Grant or award · Restricted Stock Units | +3,686 | 3,686 | ||
| 2026-05-14 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +3,686 | 3,686 | ||
| 2026-05-14 | Hawkins Richard J Director | Grant or award · Restricted Stock Units | +3,686 | 3,686 | ||
| 2026-05-14 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +3,686 | 3,686 | ||
| 2026-05-14 | Guse Kyle Director | Grant or award · Restricted Stock Units | +3,686 | 3,686 | ||
| 2026-05-14 | Guse Kyle Director | Grant or award · Stock Option (Right to Buy) | +3,686 | 3,686 | ||
| 2026-05-14 | Clowes Howard Director | Grant or award · Restricted Stock Units | +3,686 | 3,686 | ||
| 2026-05-14 | Clowes Howard Director | Grant or award · Stock Option (Right to Buy) | +3,686 | 3,686 | ||
| 2026-05-14 | ANDREWS RONALD ASBURY Director | Grant or award · Restricted Stock Units | +3,686 | 3,686 | ||
| 2026-05-14 | ANDREWS RONALD ASBURY Director | Grant or award · Stock Option (Right to Buy) | +3,686 | 3,686 | ||
| 2026-05-14 | ANDREWS RONALD ASBURY Director | Grant or award · Stock Option (Right to Buy) | +1,600 | 1,600 | ||
| 2026-05-14 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Restricted Stock Units | +3,443 | 30,055 | ||
| 2026-05-14 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +3,443 | 3,443 | ||
| 2026-05-14 | HEDRICK MARC H Chief Executive Officer | Grant or award · Restricted Stock Units | +23,834 | 170,037 | ||
| 2026-05-14 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +23,834 | 23,834 |
Page 3 of 53 · 1,048 trades